INS and diabetes mellitus: Although the prevalence of insulin monotherapy among Bangladeshi type 2 diabetes patients accounts for less than 7.3% to 14.0%53,54, further studies focusing on this group are required to provide evidence-based recommendations to maintain glycemic control for long-term diabetes patients in Bangladesh.